AV fistula - search results

If you're not happy with the results, please do another search
Bard Covera stent

e-PTFE covered stent demonstrates “significantly better” target lesion primary patency compared to angioplasty out...

The results of AVeNEW, the first level one clinical study dedicated solely to the use of a covered stent designed to treat stenosis in...
covered

Covered stent provides greater patency than angioplasty alone in AV fistulae

The Covera vascular covered stent (BD) has a superior six-month primary patency rate than standard balloon angioplasty, with an equivalent safety at 30 days,...

Bard gets US FDA premarket approval for Lutonix 035 DCB in dysfunctional AV fistulae...

Bard’s Lutonix 035 drug-coated balloon PTA catheter (DCB) has been granted premarket approval (PMA) by the US Food and Drug Administration (FDA) for a...

AV fistulas remain dialysis gold standard at any age

Comparison by interventional radiologists shows no difference in patency of arteriovenous fistulas between young and old

Lutonix AV results provide tailwind for drug-coated balloons in dysfunctional arteriovenous fistula treatment

Scott Trerotola presented the first release of eight-month data from the Lutonix AV IDE trial at the Leipzig Interventional Course (LINC; 24–27 January, Leipzig,...

BIBA Briefings: FDA approval of IN.PACT AV is a boon for management of dysfunctional...

Last month (November), the FDA approved Medtronic’s paclitaxel-coated balloon IN.PACT AV for the management of failing arteriovenous fistulae (AVF). Approval for the device was based...
endovascular

Endovascular arteriovenous fistulas “key part of any dialysis programme”

Endovascular arteriovenous fistulas (endoAVF) platforms add additional fistula options for patients and physicians, argues Dheeraj Rajan (University Health Network, University of Toronto, Toronto, Canada,...

Medtronic DCB receives US FDA approval to treat arteriovenous fistula lesions

Medtronic today announced US Food and Drug Administration (FDA) approval of the IN.PACT AV drug-coated balloon (DCB), a paclitaxel-coated balloon indicated for the treatment...

A panel of experts comments on IN.PACT AV ACCESS data

NOTE: This video is ONLY available to watch in selected countries and geographies   Jos van den Berg (Lugano, Switzerland) speaks to Andrew Holden (Auckland, New...
AV access

IN.PACT AV access trial meets primary safety and effectiveness endpoints

Medtronic has announced the first-ever results from the IN.PACT AV access clinical study comparing the investigational IN.PACT AV drug-coated balloon (DCB) to percutaneous transluminal...
breakthrough

MagicTouch AVF sirolimus-coated balloon granted FDA breakthrough device designation

Concept Medical has been granted breakthrough device designation from the US Food and Drug Administration (FDA) for MagicTouch AVF, its sirolimus drug-coated balloon (DCB)...
stem cell

Stem cell therapy shows promise in preventing venous stenosis and AVF maturation

 Sanjay Misra (Rochester, USA) talks to Interventional News about his research into whether stem cell therapy can help AVFs (arteriovenous fistulas) mature and also prevent venous...

Comparing and contrasting surgically-created AVFs with those made by endovascular means

 Nicholas Inston (Birmingham, UK) tells Vascular News at LINC 2019 about the exciting field of percutaneous arteriovenous fistula (AVF) creation, the main devices and...

BD receives FDA 510(k) clearance of WavelinQ 4F endoAVF system

BD has announced the 510(k) clearance from the US Food and Drug Administration (FDA) for the WavelinQ 4F endoAVF system earlier this month. The endoAVF...
paclitaxel

Paclitaxel DCB no better than placebo to treat stenosis in patients with arteriovenous fistulae

In a study evaluating the efficacy of a drug-coated balloon (DCB) in inhibiting restenosis and ensuring long-term patency in patients with arteriovenous fistulae (AVF),...

Lutonix Global AV Registry: DCB use prolongs time to reintervention in failing arteriovenous access

 Tobias Steinke (Dusseldorf, Germany) reported on the Lutonix Global arteriovenous (AV) Registry at CIRSE 2018 in Lisbon, Portugal. Lutonix Global AV Registry data add to...

BD acquires TVA Medical, makers of everlinQ endoAVF System

BD (Becton, Dickinson and Company) announced it has completed the acquisition of TVA Medical, a company that develops minimally invasive vascular access solutions...

FDA approves Ellipsys Vascular Access System for non-surgical dialysis fistula creation

Ellipsys Vascular Access System (Avenu Medical) has been granted De Novo marketing authorisation from the Food and Drug Administration (FDA). Ellipsys is a minimally-invasive...

everlinQ endoAVF receives FDA de novo marketing approval

everlinQ endoAVF System (TVA Medical) is now approved by the US Food and Drug Administration for de novo marketing. This innovative, minimally invasive technology...
interim

Latest data on Lutonix and IN.PACT drug-coated balloons in AV access revealed

There in an increasing physician interest in exploring the role of drug-coated balloons in arteriovenous (AV) access. At the Leipzig Interventional Course (LINC; 30...

Meta-analysis shows positive experience for patients who received an endovascular arteriovenous fistula for haemodialysis...

An international meta-analysis of clinical experience in patients who received an endovascular arteriovenous fistula (endoAVF) for haemodialysis access was presented at Leipzig Interventional Course...

Twelve-month NEAT trial data promising for everlinQ endoAVF haemodialysis access system

TVA Medical has announced the online publication of positive results from the Novel Endovascular Access Trial (NEAT) evaluating its everlinQ endoAVF system. The 12-month...

Novel arteriovenous fistula creation 
for dialysis access

Percutaneous arteriovenous fistulae creation may allow greater patient access to fistula formation as more physicians will be able to create these channels, thus potentially...

Novel, external pneumatic device may assist in fistula development

Extensive research has shown that intermittent compression and rubber tourniquets help to dilate superficial veins after fistula placement. The Fist Assist device is an...

TVA Medical presents positive everlinQ endoAVF system results at LINC 2017

TVA Medical has provided clinical updates involving its everlinQ endoAVF system at the 2017 Leipzig Interventional Course (LINC; 24–17 January, Leipzig, Germany). Scientific data were...

Percutaneously created arteriovenous fistulae need far fewer post-creation interventions than those made by traditional...

NEAT (Novel endovascular access trial) data presented at the Vascular Interventional Advances (VIVA) 2016 meeting (18–22 September, Las Vegas, USA) suggest that endovascular arteriovenous...

Medtronic IN.PACT Admiral DEB granted CE mark for treatment of AV access in patients...

The IN.PACT Admiral drug-eluting balloon (DEB) has been granted CE mark for arteriovenous (AV) access to help maintain haemodialysis access in patients with end-stage...

Interventional radiology of the occluded fistula

Scott O Trerotola, Philadelphia, USA told Interventional News that fistula declotting has become a mainstay of interventional radiology practices in the USA. He recently received a BSIR honorary membership at the annual meeting in Glasgow, UK.

TVA Medical’s catheter-based haemodialysis access system demonstrates success in clinical study

Preliminary data presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual scientific meeting (Barcelona, Spain) demonstrated that TVA Medical‰Ûªs vascular catheter-based FLEX System can create autogenous arteriovenous fistulas (AV fistulas) for haemodialysis patients with 94% procedural success.
haemodialysis

A thumbnail sketch of haemodialysis access: Past, present, and future in the USA

Bart Dolmatch gives an overview of the history of haemodialysis access in the USA, and balances the pros and cons of current access options....

Endovascular options gain ground in creation of haemodialysis lifelines

Until recently, creation, maintenance and restoration of vascular access function was entirely performed by open surgical methods. However, it is becoming apparent that endovascular...
stem cell

Promising first-time data indicate human stem cell trial is safe, prompting future efficacy study

A first-in-human, phase I clinical trial using stem cells to prevent venous stenosis formation in arteriovenous (AV) fistulas yields promising results. Sanjay Misra (Mayo...

Cagent Vascular raises US$11.87M funding

Cagent Vascular has announced the completion of US$11.87 million in Series B funding. The round was led by two strategic investors including one that...

First patient enrolled in IN.PACT arteriovenous access drug-coated balloon study

The US FDA has approved the investigational device exemption (IDE) study to evaluate the safety and efficacy of IN.PACT AV access drug-coated balloon as...

Interventional News Issue 64 – November 2016 US Edition

Highlights: 10-year EMMY results show majority undergoing embolization for symptomatic fibroids can avoid hysterectomy Percutaneously created AV fistulae need far fewer post-creation interventions than those made...

Interventional News Issue 64 – November 2016

Highlights: 10-year EMMY results show majority undergoing embolization for symptomatic fibroids can avoid hysterectomy Percutaneously created AV fistulae need far fewer post-creation interventions than those made...

Primary endpoint data from NEAT study announced at Leipzig Interventional Course 2016

Primary endpoint data from a prospective, multicentre clinical study evaluating the everlinQ endoAVF system have been announced by TVA Medical. The system is designed to...
wrapsody

Merit Medical receives FDA breakthrough device designation for Wrapsody endovascular stent graft system

Merit Medical Systems has announced that it has been granted breakthrough device designation by the US Food and Drug Administration (FDA) for the Merit...
MagicTouch

Concept Medical granted CE certification for sirolimus-coated MagicTouch group of products

Concept Medical received CE certification for their MagicTouch group of products on 16 October 2019. The CE certified products/brands are as listed below: MagicTouch—PTA (sirolimus-coated...

High-grade evidence supports use of APERTO DCB in vascular access stenosis

Jos van den Berg (Lugano, Switzerland) tells Interventional News at CIRSE 2019 that the results of the APERTO AVF China trial provide strong evidence of the benefits of...
Luminor

Luminor DCB now reimbursed in France

Luminor 18 and Luminor 35 drug-coated balloons (DCB; iVascular) are now listed on the French LPPR list for de novo lesions of the femoropopliteal...
neuroendovascular

Transradial access is safe and effective for neuroendovascular procedures

In the largest cohort study to date, new research from Jefferson (Philadelphia University and Thomas Jefferson University, Philadelphia, USA) demonstrates that transradial surgery, done...
interim

Interim results of a multicentre analysis support paclitaxel-coated balloon angioplasty

The interim results of a multicentre, European retrospective analysis investigating the use of drug-coated balloons (DCBs) in symptomatic central venous stenosis (CVS) suggest that...

US FDA panel reviews paclitaxel device data: No recommendations issued

The US Food and Drug Administration (FDA) convened today and yesterday for a General Issues Panel Meeting on the late mortality safety signal associated...

The renaissance of Lipiodol in lymphangiography and lymphatic interventions—Advertorial

This article is sponsored by Guerbet. Christof M Sommer, Thilo Hackert and Götz M Richter discuss the renaissance of Lipiodol-based lymphangiography following a decline in...
MDA

MHRA issues medical device alert for paclitaxel use in the UK

Do not use paclitaxel drug-coated balloons (DCBs) or drug-eluting stents (DESs) in the routine treatment of patients with intermittent claudication until further notice, a...

BD announces launch of UltraScore 014 Focused Force PTA Balloon

BD has announced the launch of their UltraScore 014 Focused Force percutaneous transluminal angioplasty (PTA) Balloon. This marks the first scoring balloon with sheath...
kidney

New clinical practice guidelines for management of chronic kidney disease

The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI) provides evidence-based clinical practice guidelines for haemodialysis vascular access and related complications, and...
Stenting

Reviewing five years of deep venous stenting: What comes next?

For many venous specialists, dedicated venous stents represent the future—and the promise of an ideal venous stent on the horizon is a central topic...

Med Alliance raises US$37 million to launch sirolimus drug-coated balloon

Med Alliance SA, a company developing and commercialising the first sirolimus micro-reservoir drug-coated balloon (SELUTION DCB) to treat patients suffering from peripheral artery disease...

Addressing the data deficit for drug-coated balloon use in dialysis access

The first 24-month data from the LUTONIX AV investigational device exemption trial were presented at the Charing Cross Symposium in April. These interim data...

Robert Morgan

Robert Morgan, consultant vascular and interventional radiologist, St George’s Hospital, London, chairman of the CIRSE EBIR committee and a deputy editor on CVIR, told Interventional News...
bard and bd logo

EU Mergers Commission approves acquisition of Bard by BD

The European Commission, under the EU Merger Regulation, has approved the acquisition of Bard by BD, subject to conditions. Both US-based companies supply medical...

Bob Abraham

Canada’s recent recognition as a subspecialty at the national level has helped to raise awareness amongst other disciplines, healthcare policymakers and hospital administrators. “We...

Interventional News Issue 65 – Mar 2017 US Edition

Highlights: Pill that shrinks uterine fibroids gathers early data Lutonix AV results provide tailwind for drug-coated balloons in dysfunctional arteriovenous fistula treatment Michael Dake: TEVAR’s dirty secret Goetz Richter: MIRACLE I demonstrates high tumour...

Interventional News Issue 65 – Mar 2017

Highlights: Pill that shrinks uterine fibroids gathers early data Lutonix AV results provide tailwind for drug-coated balloons in dysfunctional arteriovenous fistula treatment Michael Dake: TEVAR’s dirty secret Goetz Richter: MIRACLE I demonstrates high tumour...

Bluegrass Vascular announces strategic relationship with Merit Medical

Bluegrass Vascular has announced that it is entering into a strategic relationship with Merit Medical. The agreement will streamline European distribution of the recently...

An update on the key results of the NEAT trial

The NEAT (Novel endovascular access trial) study demonstrates the possibility of using a catheter-based system to create an endovascular arteriovenous fistula (endoAVF) in patients...

From innovation to practice: The Ellipsys vascular access system

This is an exciting time for vascular access. Minimally invasive anastomosis devices have been developed and are being utilised in the creation of percutaneous...

Gireesh Mukund Warawdekar

“Interventional radiology has always been characterised by its innovative spirit. We are now seeing progress with new procedures being developed to create percutaneous arteriovenous fistulae....

Gregory John Slater

"War (as in turf war) is an emotional word because in wars, people get hurt. I believe we truly care about the patients we...

Terumo acquires Sequent Medical

Terumo Corporation has announced that it has entered into an agreement to purchase Sequent Medical, known for its WEB aneurysm embolization device. The purchase price...

Nipro Medical launches Cronus HP high-pressure angioplasty balloon catheter in the USA

Nipro North America, a division of Nipro Medical Corporation, has launched the Cronus HP high-pressure, 0.035” over-the-wire percutaneous transluminal angioplasty balloon catheter. Cronus HP is...

Interventional radiology in trauma management

The role of interventional radiology in the management of severely traumatised patients began three to four decades ago with the embolization of the internal iliac arteries for massive pelvic bleeding. Over time, interventional radiology has progressively taken on a principal role in management of trauma patients, writes Jaime Tisnado.

NuCryo Vascular gets 510(k) clearance for next generation reusable Polarcath peripheral dilatation system

NuCryo Vascular has announced receiving 510(k) clearance on the next generation reusable Cryoplasty inflation device. The company has also announced that it will be selling the current and next generation model via a direct sales team.

Prospective multicentre study confirms safety and efficacy of percutaneous EVAR

The study confirms previous findings of single-centre studies that the procedure is associated with a high technical success rate when performed by experienced operators.

Splenic trauma: Know the limits of embolization

Management of blunt splenic trauma has substantially evolved during the past two decades. Hicham T Abada reviews the literature and outlines the limits of splenic embolization.

Aneurysm Coiling Efficiency (ACE) registry shows positive results for Ruby coil peripheral vasculature

The Aneurysm Coiling Efficiency registry offers an opportunity to study the demographics and long-term outcomes of a cohort of patients with embolization of the peripheral vasculature using Ruby coils (Penumbra).

Myths about interventional management of vascular malformations: general approach and diagnosis

Ahmad Alomari, Harvard Medical School, Boston Children‰Ûªs Hospital, Boston, USA, wrote to dispel common myths about the management and diagnosis of vascular malformations.

“Wait as long as you can to intervene”

At CIRSE Derrick Martin discussed different approaches, including interventional procedures, to managing pancreatic necrosis

Terumo introduces Azur Detachable 35 Peripheral Framing Coil

Azur (Terumo) is indicated for peripheral embolization procedures where a scaffolding structure is needed, such as: hypogastric artery embolization; peripheral arteriovenous malformations and fistulas; endoleaks; visceral aneurysms; and venous applications.

Boston Scientific launches Mustang PTA balloon catheter globally

On June 20, Boston Scientific announced the global launch of its Mustang PTA balloon catheter, a highly deliverable 0.035 inch percutaneous transluminal angioplasty (PTA) catheter designed for a wide range of peripheral angioplasty procedures.

AngioScore launches new longer AngioSculpt devices for treatment of peripheral artery disease

These new devices incorporate longer (40 mm) balloons and scoring elements in diameters 2.0, 2.5, 3.0 and 3.5mm. These new sizes are expected to be particularly useful in treating lesions typically encountered in the treatment of complex peripheral artery disease below the knee.

Opinion: Off-label use of devices and drugs by interventional radiologists

Tony Nicholson, consultant, Leeds Teaching Hospitals, NHS Trust, UK, spoke to Interventional News about the implications of off-label usage of devices and drugs by interventional radiologists.

Novel three-in-one angioplasty balloon achieves first commercial deployment successfully

The IQCath (Hotspur Technologies) enables, for the first time, performance of three complex vascular procedures with one single catheter, potentially reducing procedure time, expense and radiation exposure for patients and medical professionals.

Terumo launches Azur detachable 35 hydrocoil system

Terumo Interventional Systems has announced the full commercial availability in the United States of the Azur Peripheral HydroCoil 35 platinum coil embolization system.

Stent grafts top ‰ÛÏGold Standard‰Û balloon angioplasty for dialysis patients

New England Journal of Medicine publishes first study to show minimally invasive interventional radiology approach for end-stage kidney disease patients is ‰ÛÏsuperior‰Û in treating blocked access

Boston Scientific announces FDA clearance and CE mark for WallFlex fully covered oesophageal stent

Complete portfolio of the company‰Ûªs WallFlex stent family of self-expanding metal stents now available in US, Europe and other international markets

Opinion: Analysis on early treatment with PTFE-TIPS

Professor Ziv J Haskal MD, Vice Chair and Chief of Vascular and Interventional Radiology at the University of Maryland, Baltimore, US
radiology

Ricardo García-Mónaco

Konstantinos Katsanos

Alex Tang